You are here » About Galderma » Company History

Global Company History

Dermatology company Galderma’s detailed timeline.  Please note that products mentioned below may be known by a different brand name or may not be available or licensed within the UK or Ireland.  Please click here for a list of products available locally:

2015

Sharon Stone partners with Galderma in global campaign to prove natural looking results of aesthetic treatments in real life

2014

Nestlé S.A. (Nestlé) announces the creation of Nestlé Skin Health S.A.
Galderma becomes fully owned by Nestlé S.A.
Galderma (UK) Ltd launches CalmuridPro® 

2013

Acquisition of Swiss company Spirig AG, maker of Daylong & Excipial.
FDA approval of Mirvaso for the treatment of erythema associated with rosacea.


2012

Galderma defines its new 3-business-strategy and a new ambition statement.
Opening of a new affiliate in China.  Cetaphil Dermacontrol is launched in 6 countries.

 2011

Acquisition of Q-Med, a Swedish company specialised in aesthetic & corrective solutions.
Emervel (dermal filler range) launch in Europe and Latin America.  Launch of Cetaphil Restoraderm.
Plant extensions in France and Canada. Differin Lotion 0.1% (acne) launch in the United States.

2010

Launch of Azzalure (glabellar lines) and Oracea (Efracea) in Europe.

2009

Vectical (Silkis) launch in the United-States.

2008

Epiduo launch.
Acquisition of CollaGenex Pharmaceuticals
and its product Oracea (Efracea).
Launch of Differin 0.1% in Japan.

2007

Licensing agreements for a botulinum toxin type A and Pliaglis (topical anesthetic).
Differin 0.3% launch.

2006

Clobex Spray launch in the US.
Opening of the new R&D center in Sophia Antipolis, France.

2005

Metrogel 1% (rosacea) launch in the United-States.
For the first time, Galderma ranks Number One in D class in its markets 
(source: IMS Health, IMS dataview - D class - MAT Q3 2005 - 33 countries).

2004

Opening of a new production site in Hortolandia, Brazil.
Clobex Shampoo launch in the United-States and acquisition of Tri-Luma.

2003 

Launch of Metvix in Germany and the UK and Clobex Lotion (inflammatory skin conditions) in the US.

2002 

Licensing agreements for Tri-Luma (melasma or mask of pregnancy) and Pekiron (Loceryl Cream) in Japan.
First FDA approvals for pharmaceutical production in Montreal.

2001

Licensing agreement for Metvix (precancerous skin lesions and skin cancer treatment).
Launch of Clindagel (anti-acne).

2000

The Montreal production unit comes on stream.
Launch of Silkis (psoriasis) and acquisition of Capex Shampoo (seborrheic dermatitis).

1999

Acquisition of Loceryl (fungal nail infections), developed by Laboratoires Roche, together with the Scandinavian dermatology portfolio developed by Nycomed.

1998

Inauguration of a new R&D facility in Princeton, New Jersey, USA.
Acquisition in Brazil of Darrow’s dermatology portfolio.

1997 

UK operations established, Galderma (UK) Ltd.  Acquisition of Basotherm, a subsidiary of Boehringer. 

1996

Acquisition of a plant belonging to Wyeth-Ayerts in Montreal, Canada, to develop a state-of-the-art manufacturing plant.

1995

Launch of anti-acne treatment Differin, Galderma’s first home-grown dermatology product.

1994

Galderma inaugurates its wholly-owned production plant in Alby-sur-Chéran, near Annecy in the French Alps.

1993

Acquisition of MetroGel / Rozex to include rosacea treatments in the product portfolio.

1989

Global organisation implemented and new affiliates opened in Canada, Germany, and Spain.

1988

Galderma progressively takes over Alcon’s dermatology business, allowing it to focus exclusively on ophthalmology.

1986

Galderma’s first affiliate opens for business in France, followed by a second in Italy. The International Dermatology Research Center focuses its efforts on prescription dermatology products.

1981

Nestlé and L'Oréal form a joint venture to become the world’s leading dermatology player. Galderma is born.

1979 

L'Oréal creates its International Dermatology Research Center (CIRD) in Sophia-Antipolis, France, specialising in fundamental research into skin physiology.

 

Discover more about Galderma, a dermatology company providing dermatology solutions and aesthetic and corrective products internationally.

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos